ArticleSurgical case reports2026
A Case with a Pathological Course Resembling Ulcerative Colitis after Rectal Cancer Surgery with Diversion.
Article in Surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe development of CASE PRESENTATION: A 49-year-old man with advanced rectal cancer was treated with neoadjuvant chemotherapy followed by robot-assisted ultra-low anterior resection with diverting stoma. His postoperative course was complicated by an anastomotic leak. During the diversion period, he developed fever, diarrhea, and colonic inflammation that was initially diagnosed as diversion colitis and responded dramatically to systemic steroid therapy. Following stoma closure, recurrent anastomotic ulceration and diffuse colitis developed, again showing marked steroid responsiveness. Based on the overall clinical course, the patient was considered to have a clinical course resembling UC rather than diversion colitis. The patient achieved sustained remission with systemic steroids and mesalamine, with no recurrence of intestinal inflammation or cancer.
conclusionsThis case underscores the challenges in distinguishing UC from diversion colitis in the postoperative setting. Recurrent anastomotic inflammation with pronounced steroid responsiveness should prompt consideration of underlying UC, even after colorectal cancer surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.